{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:20:11Z","timestamp":1789154411394,"version":"build-2803163510"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,2]]},"DOI":"10.7759\/cureus.79917","type":"journal-article","created":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T08:42:26Z","timestamp":1740904946000},"source":"Crossref","is-referenced-by-count":3,"title":["Reversible Cerebral Vasoconstriction Syndrome Secondary to Paroxetine and Opioid Use in a Middle-Aged Woman: A Case Report"],"prefix":"10.7759","author":[{"given":"Evan","family":"Simonsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana N","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Newlyn","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-022-00857-4","article-title":"Pathophysiology of reversible cerebral vasoconstriction syndrome","volume":"29","author":"Chen SP","year":"2022","unstructured":"Chen SP, Wang SJ. Pathophysiology of reversible cerebral vasoconstriction syndrome. J Biomed Sci. 2022, 29:72. 10.1186\/s12929-022-00857-4","journal-title":"J Biomed Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1586\/ern.11.112","article-title":"Reversible cerebral vasoconstriction syndrome: current and future perspectives","volume":"11","author":"Chen SP","year":"2011","unstructured":"Chen SP, Fuh JL, Wang SJ. Reversible cerebral vasoconstriction syndrome: current and future perspectives. Expert Rev Neurother. 2011, 11:1265-76. 10.1586\/ern.11.112","journal-title":"Expert Rev Neurother"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S295461","article-title":"Therapeutic approaches to opioid use disorder: what is the current standard of care?","volume":"14","author":"Carley JA","year":"2021","unstructured":"Carley JA, Oesterle T. Therapeutic approaches to opioid use disorder: what is the current standard of care?. Int J Gen Med. 2021, 14:2305-11. 10.2147\/IJGM.S295461","journal-title":"Int J Gen Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/add.15636","article-title":"Opioid use disorder and the brain: a clinical perspective","volume":"117","author":"Herlinger K","year":"2022","unstructured":"Herlinger K, Lingford-Hughes A. Opioid use disorder and the brain: a clinical perspective. Addiction. 2022, 117:495-505. 10.1111\/add.15636","journal-title":"Addiction"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-021-03068-2","article-title":"Toxicities of opioid analgesics: respiratory depression, histamine release, hemodynamic changes, hypersensitivity, serotonin toxicity","volume":"95","author":"Baldo BA","year":"2021","unstructured":"Baldo BA. Toxicities of opioid analgesics: respiratory depression, histamine release, hemodynamic changes, hypersensitivity, serotonin toxicity. Arch Toxicol. 2021, 95:2627-42. 10.1007\/s00204-021-03068-2","journal-title":"Arch Toxicol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.119.024416","article-title":"Reversible cerebral vasoconstriction syndrome","volume":"50","author":"Burton TM","year":"2019","unstructured":"Burton TM, Bushnell CD. Reversible cerebral vasoconstriction syndrome. Stroke. 2019, 50:2253-8. 10.1161\/STROKEAHA.119.024416","journal-title":"Stroke"},{"key":"ref7","article-title":"Reversible cerebral vasoconstriction syndromes","author":"Nesheiwat O","year":"2024","unstructured":"Nesheiwat O, Al-Khoury L. Reversible cerebral vasoconstriction syndromes. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000006917","article-title":"RCVS(2) score and diagnostic approach for reversible cerebral vasoconstriction syndrome","volume":"92","author":"Rocha EA","year":"2019","unstructured":"Rocha EA, Topcuoglu MA, Silva GS, Singhal AB. RCVS(2) score and diagnostic approach for reversible cerebral vasoconstriction syndrome. Neurology. 2019, 92:e639-47. 10.1212\/WNL.0000000000006917","journal-title":"Neurology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(12)70135-7","article-title":"Reversible cerebral vasoconstriction syndrome","volume":"11","author":"Ducros A","year":"2012","unstructured":"Ducros A. Reversible cerebral vasoconstriction syndrome. Lancet Neurol. 2012, 11:906-17. 10.1016\/S1474-4422(12)70135-7","journal-title":"Lancet Neurol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2023.05.013","article-title":"Verapamil in the treatment of reversible cerebral vasoconstriction syndrome: a systematic review","volume":"113","author":"Collins L","year":"2023","unstructured":"Collins L, Lam L, Kleinig O, et al.. Verapamil in the treatment of reversible cerebral vasoconstriction syndrome: a systematic review. J Clin Neurosci. 2023, 113:130-41. 10.1016\/j.jocn.2023.05.013","journal-title":"J Clin Neurosci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/347848-reversible-cerebral-vasoconstriction-syndrome-secondary-to-paroxetine-and-opioid-use-in-a-middle-aged-woman-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T08:42:27Z","timestamp":1740904947000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/347848-reversible-cerebral-vasoconstriction-syndrome-secondary-to-paroxetine-and-opioid-use-in-a-middle-aged-woman-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,2]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.79917","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,2]]}}}